Trial Profile
A Phase 1, Prospective, Randomized, Two-Arm, Active Controlled, Double-Blind Study to Evaluate the Safety and Tolerability of Serum Institute of India's 10-valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Indian Young Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2019
Price :
$35
*
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 29 Sep 2013 New trial record